What Are the Important Drug Use Errors in Dialysis Patients?
- 1 September 2010
- journal article
- review article
- Published by Wiley in Seminars in Dialysis
- Vol. 23 (5), 466-469
- https://doi.org/10.1111/j.1525-139x.2010.00773.x
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Single-dose daptomycin pharmacokinetics in chronic haemodialysis patientsNephrology Dialysis Transplantation, 2009
- Pharmacokinetics and dosage adjustment in patients with renal dysfunctionEuropean Journal of Clinical Pharmacology, 2009
- The Bioartificial Kidney and Bioengineered Membranes in Acute Kidney InjuryNephron Experimental Nephrology, 2008
- Aminoglycosides in Intermittent Hemodialysis: Pharmacokinetics with Individual DosingAnnals of Pharmacotherapy, 2006
- Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis*Critical Care Medicine, 2006
- Filtering out important considerations for developing drug-dosing regimens in extended daily dialysis*Critical Care Medicine, 2006
- Pharmacokinetics and pharmacodynamics of the prophylactic dose of enoxaparin once daily over 4 days in patients with renal impairmentThrombosis Research, 2002
- Vancomycin Assay Performance in Patients with End‐Stage Renal Disease Receiving HemodialysisPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2000
- Potential Problem with Fluorescence Polarization Immunoassay Cross-Reactivity to Vancomycin Degradation Product CDP-1Therapeutic Drug Monitoring, 1989
- Isolation of peptides from uremic plasma that inhibit phenytoin binding to normal plasma proteinsClinical Pharmacology & Therapeutics, 1981